Two weeks ago, Linda Geddes, the science correspondent for The Guardian, contributed two articles, the first describing how the Covid pandemic ushered in […]
Two weeks ago, Linda Geddes, the science correspondent for The Guardian, contributed two articles, the first describing how the Covid pandemic ushered in […]
Twelve years ago, the FDA approved Hologic’s digital breast tomosynthesis (DBT) system – sometimes incorrectly referred to as 3D mammography – as […]
One of the major breakthroughs in medical science during the last two decades of the 20th century was the introduction of […]
In a long-anticipated move, this past Wednesday GE spun out its healthcare division with a listing on the NASDAQ stock exchange. After […]
At the beginning of this year, we wrote an article entitled “Understanding Breast Density,” and then in September we highlighted “World Dense Breast Day.” […]
Digital breast tomosynthesis (DBT) was approved by the FDA in 2011 as a screening modality for the early detection of […]
Delphinus Medical Technologies has just announced the closing of a $30 million investment to fast-track commercialisation of its SoftVue automated breast ultrasound […]
David Albert is the founder and chief medical officer of AliveCor, a ten-year-old company whose vision is “to be the 24/7 virtual […]
A decade ago, Siddhartha Mukherjee published his prize-winning book entitled The Emperor of All Maladies: A Biography of Cancer. He quoted from […]
Full-field digital mammography (FFDM) has been the “go to” imaging modality to screen for early detection of breast cancer for […]